Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Adrenal Function in females with low plasma HDL-C due to mutations in ABCA1 and LCAT.

Bochem AE, Holleboom AG, Romijn JA, Hoekstra M, Dallinga GM, Motazacker MM, Hovingh GK, Kuivenhoven JA, Stroes ES.

PLoS One. 2014 May 19;9(5):e90967. doi: 10.1371/journal.pone.0090967.

2.

High density lipoprotein as a source of cholesterol for adrenal steroidogenesis: a study in individuals with low plasma HDL-C.

Bochem AE, Holleboom AG, Romijn JA, Hoekstra M, Dallinga-Thie GM, Motazacker MM, Hovingh GK, Kuivenhoven JA, Stroes ES.

J Lipid Res. 2013 Jun;54(6):1698-704. doi: 10.1194/jlr.P033449.

3.

Increased risk of premature coronary artery disease in Egyptians with ABCA1 (R219K), CETP (TaqIB), and LCAT (4886C/T) genes polymorphism.

Abd El-Aziz TA, Mohamed RH, Hagrass HA.

J Clin Lipidol. 2014 Jul-Aug;8(4):381-9. doi: 10.1016/j.jacl.2014.06.001.

PMID:
25110219
4.

Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.

Holleboom AG, Daniil G, Fu X, Zhang R, Hovingh GK, Schimmel AW, Kastelein JJ, Stroes ES, Witztum JL, Hutten BA, Tsimikas S, Hazen SL, Chroni A, Kuivenhoven JA.

Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):3066-75. doi: 10.1161/ATVBAHA.112.255711.

5.

Functional LCAT is not required for macrophage cholesterol efflux to human serum.

Calabresi L, Favari E, Moleri E, Adorni MP, Pedrelli M, Costa S, Jessup W, Gelissen IC, Kovanen PT, Bernini F, Franceschini G.

Atherosclerosis. 2009 May;204(1):141-6. doi: 10.1016/j.atherosclerosis.2008.08.038.

PMID:
18922527
6.

Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT.

Lucero D, Sviridov D, Freeman L, López GI, Fassio E, Remaley AT, Schreier L.

Atherosclerosis. 2015 Sep;242(1):236-42. doi: 10.1016/j.atherosclerosis.2015.07.019. Erratum in: Atherosclerosis. 2015 Nov;243(1):59. Svidirov, Denis [corrected to Sviridov, Denis].

PMID:
26232163
7.

Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT.

Tietjen I, Hovingh GK, Singaraja R, Radomski C, McEwen J, Chan E, Mattice M, Legendre A, Kastelein JJ, Hayden MR.

Biochim Biophys Acta. 2012 Mar;1821(3):416-24. doi: 10.1016/j.bbalip.2011.08.006.

PMID:
21875686
8.
10.

Compromised LCAT function is associated with increased atherosclerosis.

Hovingh GK, Hutten BA, Holleboom AG, Petersen W, Rol P, Stalenhoef A, Zwinderman AH, de Groot E, Kastelein JJ, Kuivenhoven JA.

Circulation. 2005 Aug 9;112(6):879-84.

11.

Patients with low HDL-cholesterol caused by mutations in LCAT have increased arterial stiffness.

van den Bogaard B, Holleboom AG, Duivenvoorden R, Hutten BA, Kastelein JJ, Hovingh GK, Kuivenhoven JA, Stroes ES, van den Born BJ.

Atherosclerosis. 2012 Dec;225(2):481-5. doi: 10.1016/j.atherosclerosis.2012.09.022.

12.

Carriers of lecithin cholesterol acyltransferase gene mutations have accelerated atherogenesis as assessed by carotid 3.0-T magnetic resonance imaging [corrected].

Duivenvoorden R, Holleboom AG, van den Bogaard B, Nederveen AJ, de Groot E, Hutten BA, Schimmel AW, Hovingh GK, Kastelein JJ, Kuivenhoven JA, Stroes ES.

J Am Coll Cardiol. 2011 Dec 6;58(24):2481-7. doi: 10.1016/j.jacc.2010.11.092. Erratum in: J Am Coll Cardiol. 2012 Jan 10;59(2):196.

13.

Inherited disorders of HDL metabolism and atherosclerosis.

Hovingh GK, de Groot E, van der Steeg W, Boekholdt SM, Hutten BA, Kuivenhoven JA, Kastelein JJ.

Curr Opin Lipidol. 2005 Apr;16(2):139-45. Review.

PMID:
15767853
14.
15.

ATP-binding cassette transporter A1 locus is not a major determinant of HDL-C levels in a population at high risk for coronary heart disease.

Kakko S, Kelloniemi J, von Rohr P, Hoeschele I, Tamminen M, Brousseau ME, Kesäniemi YA, Savolainen MJ.

Atherosclerosis. 2003 Feb;166(2):285-90.

PMID:
12535741
16.

ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden.

Bochem AE, van Wijk DF, Holleboom AG, Duivenvoorden R, Motazacker MM, Dallinga-Thie GM, de Groot E, Kastelein JJ, Nederveen AJ, Hovingh GK, Stroes ES.

Eur Heart J. 2013 Jan;34(4):286-91. doi: 10.1093/eurheartj/ehs376.

17.

Cholesteryl ester transfer protein expressed in lecithin cholesterol acyltransferase-deficient mice.

Wu CA, Tsujita M, Okumura-Noji K, Usui S, Kakuuchi H, Okazaki M, Yokoyama S.

Arterioscler Thromb Vasc Biol. 2002 Aug 1;22(8):1347-53.

18.

High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations.

Holleboom AG, Kuivenhoven JA, Peelman F, Schimmel AW, Peter J, Defesche JC, Kastelein JJ, Hovingh GK, Stroes ES, Motazacker MM.

Hum Mutat. 2011 Nov;32(11):1290-8. doi: 10.1002/humu.21578.

PMID:
21901787
19.

T13M mutation of lecithin-cholesterol acyltransferase gene causes fish-eye disease.

Miida T, Zhang B, Obayashi K, Seino U, Zhu Y, Ito T, Nakamura Y, Okada M, Saku K.

Clin Chim Acta. 2004 May;343(1-2):201-8.

PMID:
15115696
20.

Lipoprotein distribution and serum concentrations of 7α-hydroxy-4-cholesten-3-one and bile acids: effects of monogenic disturbances in high-density lipoprotein metabolism.

Steiner C, Holleboom AG, Karuna R, Motazacker MM, Kuivenhoven JA, Frikke-Schmidt R, Tybjaerg-Hansen A, Rohrer L, Rentsch KM, Eckardstein Av.

Clin Sci (Lond). 2012 Apr;122(8):385-96. doi: 10.1042/CS20110482.

PMID:
22010943
Items per page

Supplemental Content

Support Center